406 related articles for article (PubMed ID: 27686254)
1. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.
Lu J; Zhang R; Hong H; Yang Z; Sun D; Sun S; Guo X; Ye J; Li Z; Liu P
Biochim Biophys Acta; 2016 Dec; 1863(12):3027-3039. PubMed ID: 27686254
[TBL] [Abstract][Full Text] [Related]
2. PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.
Li Q; Li ZM; Sun SY; Wang LP; Wang PX; Guo Z; Yang HW; Ye JT; Lu J; Liu PQ
Acta Pharmacol Sin; 2019 May; 40(5):589-598. PubMed ID: 30030529
[TBL] [Abstract][Full Text] [Related]
3. PARP1 promote autophagy in cardiomyocytes via modulating FoxO3a transcription.
Wang C; Xu W; Zhang Y; Zhang F; Huang K
Cell Death Dis; 2018 Oct; 9(11):1047. PubMed ID: 30323296
[TBL] [Abstract][Full Text] [Related]
4. The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy.
Li Z; Guo Z; Lan R; Cai S; Lin Z; Li J; Wang J; Li Z; Liu P
Acta Pharm Sin B; 2021 May; 11(5):1286-1299. PubMed ID: 34094834
[TBL] [Abstract][Full Text] [Related]
5. The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy.
Wang L; Wang P; Xu S; Li Z; Duan DD; Ye J; Li J; Ding Y; Zhang W; Lu J; Liu P
Int J Biol Sci; 2022; 18(2):783-799. PubMed ID: 35002525
[TBL] [Abstract][Full Text] [Related]
6. PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy.
Wang L; Li Z; Tan Y; Li Q; Yang H; Wang P; Lu J; Liu P
Mol Cell Endocrinol; 2018 Oct; 474():137-150. PubMed ID: 29501586
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Alemasova EE; Lavrik OI
Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.
Naumenko KN; Sukhanova MV; Hamon L; Kurgina TA; Alemasova EE; Kutuzov MM; Pastré D; Lavrik OI
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32947956
[TBL] [Abstract][Full Text] [Related]
9. The 89-kDa PARP1 cleavage fragment serves as a cytoplasmic PAR carrier to induce AIF-mediated apoptosis.
Mashimo M; Onishi M; Uno A; Tanimichi A; Nobeyama A; Mori M; Yamada S; Negi S; Bu X; Kato J; Moss J; Sanada N; Kizu R; Fujii T
J Biol Chem; 2021; 296():100046. PubMed ID: 33168626
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3.
Song G; Zhu L; Ruan Z; Wang R; Shen Y
Biochem Biophys Res Commun; 2019 Nov; 519(4):682-688. PubMed ID: 31543343
[TBL] [Abstract][Full Text] [Related]
12. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
Zhang L; Li DQ
Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
[TBL] [Abstract][Full Text] [Related]
13. PARP1 is activated by membrane damage and is involved in membrane repair through poly(ADP-ribosyl)ation.
Mashimo M; Kita M; Nobeyama A; Nomura A; Fujii T
Genes Cells; 2022 Apr; 27(4):305-312. PubMed ID: 35124853
[TBL] [Abstract][Full Text] [Related]
14. Inputs and outputs of poly(ADP-ribosyl)ation: Relevance to oxidative stress.
Hegedűs C; Virág L
Redox Biol; 2014; 2():978-82. PubMed ID: 25460733
[TBL] [Abstract][Full Text] [Related]
15. SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy.
Lu J; Sun D; Liu Z; Li M; Hong H; Liu C; Gao S; Li H; Cai Y; Chen S; Li Z; Ye J; Liu P
Transl Res; 2016 Jun; 172():96-112.e6. PubMed ID: 27016702
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase 1 induces cardiac fibrosis by mediating mammalian target of rapamycin activity.
Sun S; Hu Y; Zheng Q; Guo Z; Sun D; Chen S; Zhang Y; Liu P; Lu J; Jiang J
J Cell Biochem; 2019 Apr; 120(4):4813-4826. PubMed ID: 29278652
[TBL] [Abstract][Full Text] [Related]
17. The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1.
Feng XJ; Gao H; Gao S; Li Z; Li H; Lu J; Wang JJ; Huang XY; Liu M; Zou J; Ye JT; Liu PQ
Br J Pharmacol; 2015 Jun; 172(11):2852-63. PubMed ID: 25625556
[TBL] [Abstract][Full Text] [Related]
18. Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling.
Zhang N; Zhang Y; Qian H; Wu S; Cao L; Sun Y
Cell Death Differ; 2020 Sep; 27(9):2605-2619. PubMed ID: 32139900
[TBL] [Abstract][Full Text] [Related]
19. Replication protein A as a modulator of the poly(ADP-ribose)polymerase 1 activity.
Maltseva EA; Krasikova YS; Sukhanova MV; Rechkunova NI; Lavrik OI
DNA Repair (Amst); 2018 Dec; 72():28-38. PubMed ID: 30291044
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribosyl)ation as a new posttranslational modification of YB-1.
Alemasova EE; Pestryakov PE; Sukhanova MV; Kretov DA; Moor NA; Curmi PA; Ovchinnikov LP; Lavrik OI
Biochimie; 2015 Dec; 119():36-44. PubMed ID: 26453809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
